Key Takeaways And Market Insights: Cencora's Inaugural ThinkLive Cell And Gene Therapy Summit

Cencora's ThinkLive Cell and Gene Therapy Summit was a pivotal gathering for industry leaders, offering a comprehensive overview of the dynamic landscape of CGTs. The event showcased the growing collaboration within the sector, despite its competitive nature. Participants discussed the challenges of market access, including pricing, reimbursement, and geographic distribution, which continue to hinder patient access.

The summit also highlighted promising developments, such as advances in platform technologies and clinical trial design. Regulatory insights from the FDA emphasized the agency's commitment to early engagement with manufacturers, facilitating a smoother development process. However, funding challenges remain a significant concern, particularly for smaller companies.

As the CGT sector continues to evolve, ongoing communication, collaboration, and competition will be essential to drive innovation and improve patient outcomes. The ThinkLive Summit provided a valuable platform for fostering these relationships and shaping the future of CGTs.